EUVIMEDEUVIMED entdecken
Crossref

Multimodal Management of Superior Sulcus Tumors: Adaptive Radiotherapy with Precision PET-MRI-CT Fusion, Gradient Dose Optimization, and Clinical Outcomes in the Trimodality Era

Md. Arifur Rahman, A K M Akramul Haque, Sharmin Akter Rupa, Md. Jobairul Islam, Ahammad Al Mamun Sweet, Mashud Parvez, Qamruzzaman Chowdhury

Journal of Ahsania Mission of Cancer & General Hospital · 01.07.2026 · 79

DOI: 10.65292/jamcgh.2026.v2e2.06 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ahsania Mission of Cancer & General Hospital, online erschienen am 01.07.2026. Verfasst von Md. Arifur Rahman und 6 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Superior sulcus tumors are uncommon apical lung cancers that invade the thoracic inlet and adjacent structures including ribs, vertebrae, brachial plexus, sympathetic chain, and subclavian vessels. Contemporary management for potentially resectable disease centers on neoadjuvant concurrent chemoradiotherapy followed by surgery, guided by high-quality local staging with thoracic inlet MRI and whole-body staging with PET-CT. The strongest prospective evidence remains from the Southwest Oncology Group (SWOG) 9416 and Japan Clinical Oncology Group (JCOG) 9806 phase II trials, together with contemporary guidance from the European Society for Medical Oncology (ESMO) and ASCO/eviQ. We present a 57-year-old male with biopsy-proven moderately differentiated squamous cell carcinoma (cT4N0Mx, Stage IIIA) manifesting as a left superior sulcus mass with Pancoast syndrome and vertebral invasion at D2–D4. The patient received weekly paclitaxel–carboplatin concurrent with VMAT 54 Gy in 30 fractions using an adaptive replanning strategy, followed by left upper lobectomy. Postoperative pathology demonstrated pathological complete response (pCR). Serial PET-CT through March 2025 confirmed sustained metabolic remission. The principal technical teaching point is the value of MRI–CT fusion for posterior/apical target delineation when disease abuts vertebral bodies and the spinal canal, enabling a deliberately steep posterior dose gradient while maintaining spinal cord tolerance.

Zitieren

APA

Rahman, M. A., Haque, A. K. M. A., Rupa, S. A., Islam, M. J., Sweet, A. A. M., Parvez, M., & Chowdhury, Q. (2026). Multimodal Management of Superior Sulcus Tumors: Adaptive Radiotherapy with Precision PET-MRI-CT Fusion, Gradient Dose Optimization, and Clinical Outcomes in the Trimodality Era. Journal of Ahsania Mission of Cancer & General Hospital, 79. https://doi.org/10.65292/jamcgh.2026.v2e2.06

Vancouver

Rahman MA, Haque AKMA, Rupa SA, Islam MJ, Sweet AAM, Parvez M, et al. Multimodal Management of Superior Sulcus Tumors: Adaptive Radiotherapy with Precision PET-MRI-CT Fusion, Gradient Dose Optimization, and Clinical Outcomes in the Trimodality Era. Journal of Ahsania Mission of Cancer & General Hospital. 2026:79. doi:10.65292/jamcgh.2026.v2e2.06

BibTeX
@article{Rahman2026,
  author = {Rahman, Md. Arifur and Haque, A K M Akramul and Rupa, Sharmin Akter and Islam, Md. Jobairul and Sweet, Ahammad Al Mamun and Parvez, Mashud and Chowdhury, Qamruzzaman},
  title = {Multimodal Management of Superior Sulcus Tumors: Adaptive Radiotherapy with Precision PET-MRI-CT Fusion, Gradient Dose Optimization, and Clinical Outcomes in the Trimodality Era},
  journal = {Journal of Ahsania Mission of Cancer & General Hospital},
  year = {2026},
  pages = {79},
  doi = {10.65292/jamcgh.2026.v2e2.06}
}
Kostenlos starten →